Expected and Unexpected OFF Episodes in Parkinson’s Disease
Physicians explain expected versus unexpected OFF episodes and the use of symptom diaries in managing Parkinson’s disease.
Treating the Root of Multiple Sclerosis With ATA188: Bridget A. Bagert, MD, MPH
October 18th 2021After showing potential remyelination effects, the director of the Multiple Sclerosis Center at Ochsner Health offered her perspective on the latest data for ATA188 in progressive MS. [WATCH TIME: 4 minutes]
IPX-203 as a Parkinson Disease Treatment: Alberto J. Espay, MD, MSc
October 17th 2021In light of the RISE-PD study data, the research chair for Parkinson’s Disease and Movement Disorders at University of Cincinnati Health offered insight into IPX-203 in Parkinson disease. [WATCH TIME: 3 minutes]
Expanded Data from ULTIMATE 1 and 2 Trials of Ublituximab: Lawrence Steinman, MD
October 15th 2021The Zimmermann Professor of Neurology and Neurological Sciences, and Pediatrics at Stanford University spoke on the safety and efficacy of ublituximab in treating patients with relapsing forms of multiple sclerosis. [WATCH TIME: 4 minutes]
Grading Valuable Aspects of Mesenchymal Cell Activity in Progressive MS: Jeffrey Cohen, MD
October 14th 2021The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic provided context on whether efficacy outcomes should be weighed more than mechanistic action when evaluating MSC-NTF cell therapies. [WATCH TIME: 3 minutes]
Understanding the Challenges of Migraine Through Personal Experience: Courtney White, MD
October 14th 2021The headache specialist at Jefferson Headache Center discussed the array of issues patients with migraine face and why her personal experience may resonate with patients. [WATCH TIME: 3 minutes]
Patient Education and Awareness in NMOSD: Bruce Cree, MD, PhD, MAS, FAAN
October 13th 2021The clinical research director of the USCF Multiple Sclerosis Center discussed the importance of improving knowledge and education for patients with NMOSD, as well as strategies to do so. [WATCH TIME: 3 minutes]
Benefits to Treating Progressive MS With Mesenchymal Stem Cells: Jeffrey Cohen, MD
October 13th 2021The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the use of MSC-NTF cells in progressive MS and the data backing this approach. [WATCH TIME: 3 minutes]
Day-to-Day Care of NMOSD, Advances and Challenges: Bruce Cree, MD, PhD, MAS, FAAN
October 12th 2021Discussing the 3 FDA-approved treatments for NMOSD, the clinical research director of the UCSF Multiple Sclerosis Center commented on the positive impact, as well as resultant barriers to care. [WATCH TIME: 4 minutes]
Understanding Disadvantages to African Americans in NMOSD Trials: Evanthia Bernitsas, MD
October 12th 2021The neurologist at Wayne State University provided background on why there needs to be a continued focus on including and studying African American patients with NMOSD in trials. [WATCH TIME 3 minutes]
OFF Episodes in Parkinson’s Disease
Panelists have a conversation on the definition of OFF episodes in relation to Parkinson’s disease and how common OFF episodes are for patients.
Recent Advances and New Therapies for NMOSD: Bruce Cree, MD, PhD, MAS, FAAN
October 11th 2021The clinical research director of the UCSF Multiple Sclerosis Center provided an overview on the state of care for NMOSD, specifically the development of inebilizumab, satralizumab, and eculizumab. [WATCH TIME: 6 minutes]
Clinicians’ Role in Addressing the Neurologist Shortage: Jennifer Majersik, MD, MS
October 10th 2021The division chief of vascular neurology at the University of Utah discussed the individual role that clinicians and neurologists can play to increase interest in the field of neurology. [WATCH TIME: 2 minutes]
Improving Surgery Communication, Risk Factor Assessment for Older Adults: Susana Vacas, MD, PhD
October 8th 2021Following the publication of a recent article outlining the association of the use of anesthesia during surgery and cognitive decline in older adults, the assistant professor of anesthesiology at the David Geffen School of Medicine, UCLA, spoke on the need to assess risk factors. [WATCH TIME: 5 minutes]
Managing MS in the Community: Advice and Resources
Advice and resources for colleagues, including community practitioners and neurologists, to encourage collaboration and best support for patients with multiple sclerosis (MS).
Educating Children, Adolescents With Epilepsy About Diets: Robyn Blackford, RD, LDN
October 8th 2021The registered dietician at Ann & Robert H. Lurie Children’s Hospital of Chicago provided insight on the importance of educating youths with epilepsy on diets, especially in the transition stages of care. [WATCH TIME: 2 minutes]
An optimistic look at the future management of multiple sclerosis (MS) based on newer treatment options and ongoing research in the field.